Title:
FUSED BICYCLIC DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT, CRYSTAL FORM THEREOF AND PREPARATION METHOD THEREFOR
Document Type and Number:
WIPO Patent Application WO/2023/041061
Kind Code:
A1
Abstract:
Provided are a fused bicyclic derivative, a pharmaceutically acceptable salt, a crystal form thereof and a preparation method therefor. Specifically, provided are a hydrochloride, a mesylate, an acetate and a tartrate of the compound of formula (I), and a preparation method therefor and a crystal form thereof.
Inventors:
SHANG TINGTING (CN)
ZHAO MIAOMIAO (CN)
YANG JUNRAN (CN)
DU ZHENXING (CN)
WANG LIN (CN)
SHAO QIYUN (CN)
FENG JUN (CN)
HE FENG (CN)
ZHAO MIAOMIAO (CN)
YANG JUNRAN (CN)
DU ZHENXING (CN)
WANG LIN (CN)
SHAO QIYUN (CN)
FENG JUN (CN)
HE FENG (CN)
Application Number:
PCT/CN2022/119402
Publication Date:
March 23, 2023
Filing Date:
September 16, 2022
Export Citation:
Assignee:
JIANGSU HENGRUI PHARMACEUTICALS CO LTD (CN)
SHANGHAI HENGRUI PHARMACEUTICAL CO LTD (CN)
SHANGHAI HENGRUI PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D239/70; A61K31/517; A61P35/00; C07D401/14; C07D487/08
Domestic Patent References:
| WO2006071819A1 | 2006-07-06 | |||
| WO2021185238A1 | 2021-09-23 | |||
| WO2006071819A1 | 2006-07-06 | |||
| WO2008075109A1 | 2008-06-26 | |||
| WO2009006040A2 | 2009-01-08 |
Foreign References:
| CN101918373A | 2010-12-15 | |||
| CN101003537A | 2007-07-25 | |||
| CN107074867A | 2017-08-18 | |||
| CN202111089990A | 2021-09-17 | |||
| US8377937B2 | 2013-02-19 | |||
| US20100120801A1 | 2010-05-13 | |||
| CN2021081033W | 2021-03-16 |
Other References:
J. MED. CHEM., vol. 55, 2012, pages 8110 - 8127
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: